Adjunctive use of glucagon-like peptide-1 receptor agonists after bariatric surgery: updated systematic review and meta-analysis of randomized controlled trials
Acta Diabetologica · 23.06.2026 · 63 (11) · 1861-1870
DOI: 10.1007/s00592-026-02730-4 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Acta Diabetologica, online erschienen am 23.06.2026. Verfasst von Sakshi Arora und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guru Gobind Singh Medical College and Hospital, Faridkot, India. Hauptthemen laut MEDLINE: Bariatric Surgery, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
AIMS: We meta-analyzed randomized trials to assess efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) after bariatric surgery. METHODS: We searched PubMed, Embase, and Cochrane Central for randomized trials comparing GLP-1 RAs with placebo after bariatric surgery. Primary outcomes were change in body weight (kg) and HbA1c (%) at 6 and 12 months. We also assessed percent total body weight loss (%TBWL), quality of life, and adverse events. We pooled mean differences (MDs) with 95% confidence intervals (CIs) using random effects and assessed heterogeneity with I² statistic. We also performed an exploratory subgroup analysis that compared very early (≤ 2 months) versus late (≥ 18 months) initiation after surgery. RESULTS: Seven RCTs (n = 460) met inclusion criteria; all evaluated liraglutide. GLP-1 RAs increased weight loss at 6 months (MD - 5.33 kg; 95% CI - 9.42 to - 1.23; p = 0.02) but not at 12 months (MD - 5.05 kg; 95% CI - 22.14 to 12.05; p = 0.33). GLP-1 RAs increased %TBWL at 6 months (MD 5.13%; 95% CI 2.14 to 8.11; p = 0.007) but not at 12 months (MD 3.96%; 95% CI - 3.33 to 11.26; p = 0.18). HbA1c did not differ at 6 or 12 months. Quality of life improved at 6 months in the trials reporting this outcome. Gastrointestinal adverse events were similar between groups. Subgroup analyses suggested differences by initiation timing. CONCLUSION: GLP-1 RA therapy improved short-term weight outcomes after bariatric surgery, with no statistically significant between-group differences at 12 months. Timing of initiation may influence response and should be explored in trials with longer follow up. TRIAL REGISTRY: PROSPERO ID CRD420251251321.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guru Gobind Singh Medical College and Hospital, Faridkot, India.
- Services institute of Medical Sciences, Lahore, Pakistan.
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
- Caucasus International University, Tbilisi, Georgia.
- Gomal Medical College, Dera Ismail Khan, Pakistan.
- Fundação Técnico Educational Souza Marques, Rio de Janeiro, Brazil.
Zitieren
APA
Arora, S., Amna, F., Akbarpoor, F., Rajdeep, D., Khalid, M., Machado, G. M., Maalin, N., Rehman, A. U., & Abreu, M. (2026). Adjunctive use of glucagon-like peptide-1 receptor agonists after bariatric surgery: updated systematic review and meta-analysis of randomized controlled trials. Acta Diabetologica, 63(11), 1861-1870. https://doi.org/10.1007/s00592-026-02730-4
Vancouver
Arora S, Amna F, Akbarpoor F, Rajdeep D, Khalid M, Machado GM, et al. Adjunctive use of glucagon-like peptide-1 receptor agonists after bariatric surgery: updated systematic review and meta-analysis of randomized controlled trials. Acta Diabetologica. 2026;63(11):1861-1870. doi:10.1007/s00592-026-02730-4
BibTeX
@article{Arora2026,
author = {Arora, Sakshi and Amna, Fnu and Akbarpoor, Fatemeh and Rajdeep, Dhvanit and Khalid, Muhammad and Machado, Gabriel Moura and Maalin, Niman and Rehman, Asad Ur and Abreu, Marconi},
title = {Adjunctive use of glucagon-like peptide-1 receptor agonists after bariatric surgery: updated systematic review and meta-analysis of randomized controlled trials},
journal = {Acta Diabetologica},
year = {2026},
volume = {63},
number = {11},
pages = {1861--1870},
doi = {10.1007/s00592-026-02730-4}
}
EUVIMED